摘要
Abstract
Objective To analyze the current situation of R&D investment in China's pharmaceutical manufacturing industry,explore its impact on technological innovation output,and provide relevant suggestions for investment in health and health technological innovation.Methods Data were collected from 31 provinces,autonomous regions,and municipalities in mainland China(excluding Hong kong,Macao and Taiwan)from January 2009 to December 2020,including research and experimental development(R&D)expenditures,number of R&D active enterprises,R&D personnel,full-time equivalent of R&D personnel,annual per capita health expenses,number of health personnel per thousand people,average education years per person,and number of effective invention patents.Descriptive statistical analysis was used to examine the changing trends and regional disparities in R&D investment in the pharmaceutical manufacturing industry.A panel data econometric model was established to analyze the impact of R&D investment in the pharmaceutical manufacturing industry on the number of effective invention patents.Results From 2009 to 2020,the total R&D investment in China's pharmaceutical manufacturing industry increased from 15.45 billion yuan to 90.65 billion yuan,an overall increase of 486.7%,with an average annual increase of 17.5%.The results of the panel econometric model showed that the number of innovative enterprises,R&D investment in pharmaceutical manufacturing industry and annual per capita health expenditure had a statistically significant impact on the number of effective invention patents.Specifically,for every additional R&D activity enterprise,the number of effective invention patents increased by 3.884.For every 10000 yuan increase in R&D investment,0.004 effective invention patents will be added.Every time the annual per capita health expenditure increased by 1 yuan,the number of effective invention patents increased by 0.081.Conclusion From 2009 to 2020,the R&D investment in China's pharmaceutical manufacturing industry has a positive impact on promoting technological innovation.It is recommended to further strengthen support for pharmaceutical innovation enterprises in the future,continue to increase R&D investment in the pharmaceutical manufacturing industry,and promote the development of the health service industry,in order to accelerate China's health technological innovation.关键词
医药制造业/科技创新/研究与试验发展投入/专利产出Key words
Pharmaceutical manufacturing industry/Technological innovation/Investment in research and experimental development/Patent output分类
管理科学
